packageMetreleptin

metreleptin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Metreleptin is a protein drug used to treat lipodystrophy, including acquired and familial partial forms. It is authorised in the European Union, but carries a boxed warning, so its use is limited.

Summary written by glm-5.3-flash from Wikidata Q17143468 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:metreleptin
ATC codes:A16AA07
DrugBank:DB09046
Wikidata:Q17143468
molar mass:16155.4 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown